Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +34.35%
#2 Siren Siren +31.73%
#3 OriginTrail OriginTrail +18.20%
#4 Purr Purr +17.28%
#5 龙虾 (Lobster) 龙虾 (Lobster) +12.28%
#6 Ethena Staked ENA Ethena Staked ENA +11.62%
#7 Wrapped XPL Wrapped XPL +11.23%
#8 DigiByte DigiByte +11.00%
#9 Collect on Fanable Collect on Fanable +10.98%
#10 Plasma Plasma +10.85%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Rang in aandelen #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Aandeelprijs
$50.82
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$102.09M
Verandering (1 dag)
1.90%
Verandering (1 jaar)
-
Land
US
Handel Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Categorie

Healthcare
Prijs COAG met de marktkapitalisatie van B
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
COAG
$50.82
Marktkapitalisatie van Hemab Therapeutics Holdings, Inc. Common Stock(COAG)
Marktkapitalisatie: $102.09M
Vanaf August 2026 heeft Hemab Therapeutics Holdings, Inc. Common Stock een marktkapitalisatie van $102.09M. Dit maakt Hemab Therapeutics Holdings, Inc. Common Stock volgens onze gegevens het 21709th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Hemab Therapeutics Holdings, Inc. Common Stock van 2026 tot 2026
COAG vergeleken met de top 5 populairste stocks
Prijs voor COAG Aandeel B Marktkapitalisatie van B uitslagen
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,594,322 $102.09M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +5,104,822.70%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,263,459 $102.09M
Apple Inc. Apple Inc.
AAPL
$4.547T +4,453,775.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,072,162 $102.09M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +4,077,354.21%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,788,562 $102.09M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,519,305.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,390,338 $102.09M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,735,708.14%